Showing results (71-80 of 143) with videos related to
Sort By:
Pageof 15
World Journal of Surgery|May 28, 2015
National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall SurvivalYoshiaki Murakami, Sohei Satoi, Masayuki Sho, et al.Pharmacogenetics|October 30, 2003
Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9)Kazuma Kiyotani, Hiroshi Yamazaki, Masaki Fujieda, et al.Annals of Surgery|January 7, 2017
Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal MetastasisSohei Satoi, Tsutomu Fujii, Hiroaki Yanagimoto, et al.World Journal of Surgery|June 17, 2017
Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor SizeMasanao Kurata, Goro Honda, Yoshiaki Murakami, et al.Journal of Hepato-Biliary-Pancreatic Sciences|January 21, 2021
Landmarks and techniques to perform minimally invasive liver surgery: A systematic review with a focus on hepatic outflowKazuteru Monden, Felipe Alconchel, Giammauro Berardi, et al.Journal of Hepato-Biliary-Pancreatic Sciences|October 10, 2017
Comprehensive data of 3,820 patients newly diagnosed with colorectal liver metastasis between 2005 and 2007: report of a nationwide survey in JapanKatsunori Sakamoto, Goro Honda, Toru Beppu, et al.Gut and Liver|April 6, 2013
Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinomaTaku Tabata, Terumi Kamisawa, Seiichi Hara, et al.Journal of Hepato-Biliary-Pancreatic Sciences|February 2, 2021
Surgical approaches for minimally invasive distal pancreatectomy: A systematic reviewDaisuke Ban, Giovanni Maria Garbarino, Yoshiya Ishikawa, et al.World Journal of Surgery|October 10, 2018
Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic AdenocarcinomaFuyuhiko Motoi, Yoshiaki Murakami, Ken-Ichi Okada, et al.BMC Cancer|March 23, 2019
Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patientsShuichi Aoki, Fuyuhiko Motoi, Yoshiaki Murakami, et al.Pageof 15